Unique ID issued by UMIN | UMIN000041315 |
---|---|
Receipt number | R000046884 |
Scientific Title | Randomized controlled trial of liver retraction methods for laparoscopic gastrectomy and gastric tube reconstruction. |
Date of disclosure of the study information | 2020/08/04 |
Last modified on | 2020/08/03 21:04:03 |
Randomized controlled trial of liver retraction methods for laparoscopic gastrectomy and gastric tube reconstruction.
A comparative study of liver retraction methods for laparoscopic gastric surgery.
Randomized controlled trial of liver retraction methods for laparoscopic gastrectomy and gastric tube reconstruction.
A comparative study of liver retraction methods for laparoscopic gastric surgery.
Japan |
Laparoscopic gastorectomy for gastric cancer or laparoscopic gastric tube reconstruction for esophageal/esophagogastric junctional cancer
Gastrointestinal surgery |
Malignancy
NO
To indicate the safety and efficacy of using a silicone disk together with intraoperative liver retraction in patients undergoing laparoscopic gastrectomy and gastric tube reconstruction.
Safety,Efficacy
Change rate of AST and ALT from 1 day after the surgery
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Device,equipment |
Using nlyf the Nathanson liver retractor during liver retraction in laparoscopic surgery.
Placing a silicon disc between the Nathanson liver retractor and the liver during liver retraction in laparoscopic surgery.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
Patients undergoing laparoscopic gastrectomy (distal gastrectomy, proximal gastrectomy, total gastrectomy, partial resection) for gastric cancer or laparoscopic gastric tube reconstruction for esophageal cancer/esophagogastric junctional cancer.
Patients were excluded in case that the preoperative contrast-enhanced CT examination reveals the extraordinary blood vessels (accessory LHA, replaced LHA) , and the investigator determined that it was difficult to preserve in the surgery.
Patients who are scheduled to undergo simultaneous surgery for synchronous cancers or cholelithiasis.Patients were also excluded if they had severe heart disease(NYHA III-IV), liver and renal dysfunction, uncontrollable diabetes(HbA1c>8.0%), and pregnancy.
90
1st name | Hiroya |
Middle name | |
Last name | Takeuchi |
Hamamatsu University School of Medicine
Department of Surgery
4313192
1-20-1 Handayama, Higashi-ku, Hamamatsu, JAPAN
053-435-2279
takeuchi@hama-med.ac.jp
1st name | Wataru |
Middle name | |
Last name | Soneda |
Hamamatsu University School of Medicine
Department of Surgery
4313192
1-20-1 Handayama, Higashi-ku, Hamamatsu, JAPAN
053-435-2279
41235344@hama-med.ac.jp
Hamamatsu University School of Medicine
Hamamatsu University School of Medicine
Self funding
Ethics Committee of Hamamatsu University School of Medicine (EC HUSM)
1-20-1 Handayama, Higashi-ku, Hamamatsu, JAPAN
053-435-2680
rinri@hama-med.ac.jp
NO
2020 | Year | 08 | Month | 04 | Day |
Unpublished
Preinitiation
2020 | Year | 06 | Month | 15 | Day |
2020 | Year | 08 | Month | 03 | Day |
2022 | Year | 05 | Month | 31 | Day |
2020 | Year | 08 | Month | 04 | Day |
2020 | Year | 08 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046884
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |